Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

Senator Josh Hawley wants Congress to revoke the FDA's approval of mifepristone and ban the abortion pill nationally. His bill has stalled in committee, and in September he began pressing Republicans to sign a pledge backing it.

Conceptual image of generic white tablets in a blister pack beneath a shadow resembling the U.S. Capitol.
Conceptual illustration; the tablets do not depict a specific mifepristone product.

Case period:

Published by The Dispute Index editorial teamPublished Updated

Overview

On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and let women who say chemical abortion harmed them sue its manufacturers. Mifepristone has been approved in the United States since 2000 and is used in a large majority of American abortions. Hawley argues a national ban is the only remedy because the drug can be mailed into states whose own laws restrict abortion. The bill drew seven Republican cosponsors but has not moved out of the Senate Health, Education, Labor and Pensions Committee. On September 16, 2026, Hawley unveiled a four-page "Declaration for Life" and began asking officeholders and candidates to sign it as a commitment to ban the drug. The dispute is over whether Congress should enact that ban.

Read the full background

This case classifies responses to Hawley's proposition that Congress should ban mifepristone by revoking its federal approval. Responses are recorded against that proposition, not against abortion generally and not against the separate question of whether the Trump administration should act through the FDA.

The bill is S. 4066 (opens in a new tab), introduced March 11, 2026 and referred to the Senate Health, Education, Labor and Pensions Committee, where it remains. Its seven Republican cosponsors joined on staggered dates: John Cornyn (March 12), Marsha Blackburn (March 18), Ted Budd (March 23), Tommy Tuberville (March 25), Bernie Moreno (April 15), James Lankford (April 20) and Mike Rounds (June 23). None has withdrawn, and none has joined since June. The identical House companion, H.R. 7902, was introduced by Diana Harshbarger on March 12, 2026 and is likewise unmoved. Cosponsorship is a legislative act rather than a public statement; of the seven, only Cornyn has made an attributed public comment, which is recorded separately.

Hawley's central safety claim, that roughly one in ten women suffer serious complications, rests on a 2025 paper from the Ethics and Public Policy Center. PolitiFact (opens in a new tab) reported that the paper was not peer reviewed, did not disclose its data source, and was criticised by more than 250 reproductive health researchers; recategorised under the FDA's own definitions the same data yields rates of 0.10 percent for sepsis, 0.15 percent for blood transfusion and 0.22 percent for life-threatening events. The FDA has said it has identified no new safety concerns with the drug. We record this because both sides argue from it, not to settle the dispute.

Susan Collins and Lisa Murkowski were the only Republican senators who declined to sign a letter to the Department of Health and Human Services calling for a mifepristone crackdown, and their spokespeople did not answer questions about this bill. Non-response is not a position and no record is created for it.

People in this case

Timeline

4 timeline entries on this page. Dates: March 11, 2026 to September 16, 2026

  1. March 2026

    1. Hawley introduces the Safeguarding Women from Chemical Abortion Act

      Incident

      Senator Josh Hawley introduced S. 4066, the Safeguarding Women from Chemical Abortion Act, and announced it at a Capitol Hill press conference with anti-abortion movement leaders. The bill would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. It was referred to the Senate Committee on Health, Education, Labor and Pensions. An identical House companion, H.R. 7902, was introduced by Representative Diana Harshbarger the following day.

      [01]United States Congress

      The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack published record (bill 428713) on September 18, 2026, because congress.gov blocked access: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.

      S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
      [02]Josh Hawley

      Source excerpt

      The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse.

      Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.

      Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
    2. Harshbarger introduces the House companion bill

      Diana Harshbarger introduced H.R. 7902, the House companion proposing to withdraw mifepristone's approval for pregnancy termination and create a federal damages claim.

      [03]H.R. 7902 as introduced in the House

      Diana Harshbarger introduced H.R. 7902, the House companion proposing to withdraw mifepristone's approval for pregnancy termination and create a federal damages claim.

      H.R. 7902 as introduced in the HouseOfficial introduced bill, header and sections 2-3
  2. June 2026

    1. Seven Republican senators cosponsor the bill over three months, then recruitment stops

      Incident

      Seven Republican senators signed on as cosponsors of S. 4066 on staggered dates: John Cornyn on March 12, Marsha Blackburn on March 18, Ted Budd on March 23, Tommy Tuberville on March 25, Bernie Moreno on April 15, James Lankford on April 20 and Mike Rounds on June 23. None subsequently withdrew, and no further senator joined after that date. The bill received no committee action. Cosponsorship is a legislative act rather than a public statement, and of the seven only Cornyn has made an attributed public comment on the bill.

      [01]United States Congress

      The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack published record (bill 428713) on September 18, 2026, because congress.gov blocked access: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.

      S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
  3. September 2026

    1. Hawley unveils a "Declaration for Life" pledge and asks candidates to sign it

      Incident

      At the close of the first Missouri Prayer Breakfast, held in the Kennedy Caucus Room of the Russell Senate Office Building, Hawley unveiled a four-page "Declaration for Life" drafted by more than 30 pastors and signed by more than 100 Missouri pastors and about 50,000 citizens. The document calls on Congress to ban mifepristone, arguing that state abortion restrictions are insufficient because the drug can be mailed across state lines. Hawley said he would ask officeholders and candidates in both parties to sign it. Tony Perkins of the Family Research Council and the Christian musician Sean Feucht joined him at the unveiling. Reporting at the time noted the bill had not received much discussion within the Senate Republican conference since its introduction.

      [04]Josh Hawley

      Source excerpt

      This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion.

      The primary record of the Declaration for Life, the pledge Hawley is asking officeholders and candidates to sign. The declaration states that the abortion drug is "nearly always fatal to the unborn child and frequently injurious to the mother," that mifepristone "can now be mailed into every state and city in America, regardless of local rules," and calls on Congress "to ban the chemical abortion drug mifepristone."

      Hawley Unveils Declaration for Life with Christian Leaders · Josh HawleyOfficial Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.
      [05]The Hill

      Source excerpt

      Hawley's mifepristone bill has at least seven Republican co-sponsors but hasn't received much discussion within the Senate GOP conference since he introduced it.

      Contemporaneous reporting on the September 16 event, naming Tony Perkins of the Family Research Council and the Christian musician Sean Feucht as joining Hawley at the unveiling, and recording Hawley's request that candidates in both parties sign the pledge. The same quotations appear in the syndicated version carried by Yahoo News.

      Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.

Claims

Claims separate what was said from what is contested. Follow each source for the original wording and context.

What's disputed

Disputed claim

Josh Hawley

The science is clear that the chemical abortion drug is inherently dangerous to women and prone to abuse.

Sources (2)

Disputed claim

Jamila Perritt

The science is clear that mifepristone is safe, is effective, and remains medically indicated.

Sources (1)
  • Senate Introduces Attack on Mifepristone · Physicians for Reproductive HealthOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.

Disputed claim

Josh Hawley

A national ban is the only effective remedy, because mifepristone can be mailed into states whose own laws restrict abortion.

Sources (1)
View all 6 disputed claimsShow fewer disputed claims

Response record

Responses

Choose one response filter, or select All responses to see the full record.

31 responses. First 6 shown initially. Newest first.

  1. GenBioProManufacturer of generic mifepristone, in an emailed reply from its public relations firm, Feldman Strategies

    Before this statement

    Dispute Index wrote to GenBioPro's media address on September 25, 2026, noting that the bill would withdraw the drug's approval for ending a pregnancy and let women who say it harmed them sue manufacturers, and asked for the company's response.

    "At this time, the company prefers not to comment."
    Explicitly stayed out

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    GenBioPro, which makes a generic version of mifepristone, declined to comment on Sen. Josh Hawley's bill to ban the drug, in an emailed reply sent on its behalf by its public relations firm.

    After the statement

    Dispute Index had not found a public statement from GenBioPro on the bill when it wrote on September 25.

    Emailed reply from GenBioPro to Dispute Index declining to comment on Hawley's mifepristone bill · GenBioProEmailed reply on behalf of GenBioPro from Feldman Strategies, September 25, 2026 (UTC).

    Why this label?

    The reference point is Sen. Josh Hawley's proposal to ban mifepristone by withdrawing the drug's approval for ending a pregnancy. Asked for its response to the bill, GenBioPro said through its public relations firm that it prefers not to comment at this time, so we used Explicitly stayed out. The closest competing label is a finding that this is not a position event at all; it loses because the company was asked directly for its position and declined to give one.

    This label describes the statement's response within the context above.

  2. Josh HawleyUnited States senator from MissouriDirectly involved

    Before this statement

    In an interview after Overton's Senate HELP Committee hearing, Hawley said he wanted the FDA under her leadership to end abortion-drug availability in Missouri and every other state.

    "We've got to make sure that she is committed to ending the abortion drugs' availability in the state of Missouri and every other state. That they're going to put back in place the safety restrictions and they're going to follow the law."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    After a Senate hearing for FDA commissioner nominee Heidi Overton, Hawley urged the FDA under her leadership to end abortion-drug availability in Missouri and every other state and restore safety restrictions.

    After the statement

    Politico and Fierce Biotech separately reported that Hawley challenged Overton during the hearing over mifepristone regulation and its labeling.

    Overton skirts senators' questions on abortion pill · PoliticoParagraph beginning "Missouri Republican Josh Hawley" and the article's report of the Senate HELP Committee hearing.
    Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearingParagraphs beginning "Senator Josh Hawley" and "In court, Hawley said."

    Why this label?

    This statement concerns potential FDA action and does not by itself establish Hawley's position on congressional enactment.

    This label describes the statement's response within the context above.

  3. Tony PerkinsPresident of the Family Research Council, speaking at the Declaration for Life unveiling

    Before this statement

    Perkins noted that the Republican Party removed its call for a national abortion ban from the official party platform in the summer of 2024.

    "Unfortunately the Republican Party has lost its voice on the life issue and in that vacuum there are leaders that are stepping forward like Sen. Hawley calling upon the church, communities and the country to step up on behalf of the unborn."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Speaking at the unveiling of the Declaration for Life, Family Research Council president Tony Perkins said the Republican Party had lost its voice on abortion after removing a national abortion ban from its 2024 platform, and praised Hawley for stepping into that vacuum. He said his organisation would circulate the declaration as a standard for candidates to commit to.

    After the statement

    Perkins said pro-life groups would circulate the declaration "as a standard" because the party platform had dropped its life provisions.

    Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.

    Why this label?

    Perkins endorses both the proposition and the campaign to bind candidates to it, and commits his organisation to enforcing it. The closest competing label is condemns, because the sentence is framed as criticism. That loses because its target is the Republican Party's retreat from the issue, not Hawley's proposal, which he praises; classifying on the emotional tone of the criticism rather than its stated target would reverse the label.

    This label describes the statement's response within the context above.

  4. Josh HawleyUnited States Senator for Missouri, at the first Missouri Prayer Breakfast in the Russell Senate Office Building and in a subsequent official press releaseDirectly involved

    Before this statement

    S. 4066 had drawn no new cosponsor since June 23 and had received no committee action. Reporting at the time noted the bill had not been much discussed within the Senate Republican conference.

    "This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Six months after his bill stalled in committee, Hawley unveiled a four-page "Declaration for Life" drafted by more than 30 pastors, which calls on Congress to ban mifepristone on the grounds that state abortion restrictions cannot stop the drug being mailed across state lines. He said he would ask officeholders and candidates in both parties to sign it as a commitment to end chemical abortion, and renewed his request for a vote on his legislation.

    After the statement

    Tony Perkins of the Family Research Council said anti-abortion groups would circulate the declaration as a standard for candidates. The pledge is modelled on the Taxpayer Protection Pledge used to bind Republicans against tax increases.

    Hawley Unveils Declaration for Life with Christian Leaders · Josh HawleyOfficial Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.
    Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.

    Why this label?

    Here he not only restates the proposition but attaches a loyalty mechanism to it, asking candidates to pledge support for the ban. The closest competing label is “Mixed or conditional”, because the statement is addressed to Christians and churches rather than to legislators and could be read as a cultural appeal rather than a legislative demand. That loses because the declaration's own operative request is that Congress ban the drug, and Hawley paired the unveiling with a renewed call for a vote on his bill.

    This label describes the statement's response within the context above.

  5. U.S. Conference of Catholic BishopsCommittee on Pro-Life Activities of the national conference of Catholic bishops, in a letter signed by its chairman, Bishop Daniel E. Thomas of Toledo

    Before this statement

    The letter is addressed to Senator Josh Hawley and Representative Diana Harshbarger and refers to the bill by its Senate and House numbers, S. 4066 and H.R. 7902. It describes the bill as withdrawing the FDA's approval of mifepristone for abortion, making labeling the drug for that purpose unlawful, and giving people injured by the drug a legal remedy against its manufacturers. Earlier in the letter, the committee says the U.S. bishops have opposed mifepristone remaining on the market and have advocated at the very least restoring the drug's Risk Evaluation and Mitigation Strategies, and that removing the in-person dispensing requirement would seem likely to increase risks to women.

    "In withdrawing FDA approval of mifepristone for abortion, prohibiting its being labeled for abortion, and ensuring a private right of action against manufacturers, the Safeguarding Women from Chemical Abortion Act, would likely save lives by curtailing the incidence of chemical abortion itself and all of its associated risks to the mothers as well. We are very grateful for your leadership in addressing this serious moral issue, and we urge your colleagues in both the House and Senate to support and pass this bill."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    The U.S. Conference of Catholic Bishops' Committee on Pro-Life Activities wrote to Senator Josh Hawley and Representative Diana Harshbarger to support the Safeguarding Women from Chemical Abortion Act, said that withdrawing the FDA's approval of mifepristone for abortion would likely save lives, and urged their colleagues to pass the bill.

    After the statement

    The letter closes by thanking Senator Hawley and Representative Harshbarger for their work and saying the committee stands ready to support their efforts.

    Letter to Congress on the Safeguarding Women from Chemical Abortion Act (April 1, 2026)Fifth paragraph and first sentence of the sixth paragraph of the letter, before the closing

    Why this label?

    The committee states its support for the Safeguarding Women from Chemical Abortion Act, says withdrawing FDA approval of mifepristone would likely save lives, and urges Congress to pass the bill. That is direct support for Hawley's proposal that Congress ban mifepristone by withdrawing its FDA approval, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  6. Tommy TubervilleUnited States Senator for Alabama, in an official press release announcing that he joined Hawley's billDirectly involved

    Before this statement

    Hawley introduced the Safeguarding Women from Chemical Abortion Act on March 11, 2026. Tuberville's release, dated March 26, said he had joined Hawley in introducing it.

    "One in ten women who take this drug suffer serious health problems and it needs to be banned. These companies need to be put out of business and forced to pay the price for the damage they’ve caused. I’m proud to join this legislation with Sen. Hawley to ban mifepristone and empower the women who have been harmed to hold these pharmaceutical companies accountable."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Senator Tommy Tuberville said one in ten women who take mifepristone suffer serious health problems and that the drug needs to be banned. He also said he was proud to join Hawley's bill, which would let harmed women sue the drug's manufacturers.

    After the statement

    The release listed the bill's provisions, including withdrawing the FDA's approval of mifepristone for abortion and creating a private right of action against manufacturers. Separately, PolitiFact reported on May 26, 2026 that Republican senators had cited a figure of 1 in 10 women experiencing serious complications, and that the figure comes from a report by a conservative nonprofit that was not published in a peer-reviewed medical journal and that more than 250 reproductive health researchers criticized. The PolitiFact article did not name Tuberville.

    Tuberville Takes Action to Ban Dangerous Abortion Drug · Tommy TubervillePress release dated March 26, 2026, second paragraph (remarks attributed to Tuberville).
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
    Amid efforts to restrict mifepristone access, here’s what studies say about the medication · PolitiFactThird paragraph, on the one-in-ten complication figure.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Tuberville said the drug needs to be banned and that he was proud to join Hawley's legislation to do it. That is direct support for the ban, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

View all 31 responsesShow fewer responses
  1. Center for Reproductive RightsLegal advocacy organization, in its U.S. Repro Watch news update

    Before this statement

    Hawley introduced the Safeguarding Women from Chemical Abortion Act on March 11, 2026. His office said the bill would withdraw the FDA's approval of mifepristone for abortion.

    "Federal lawmakers are attempting to ban mifepristone. Republican Senator Josh Hawley and other lawmakers are urging the FDA to rescind its approval of the abortion pill mifepristone, despite its decades-long safety record."
    Condemned

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    In its U.S. Repro Watch update of March 24, 2026, the Center for Reproductive Rights said federal lawmakers, including Sen. Josh Hawley, are attempting to ban mifepristone and are urging the FDA to rescind its approval despite the drug's decades-long safety record.

    After the statement

    The same item says the Trump administration is also conducting its own safety review of mifepristone, which the Center calls politically motivated.

    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The case's reference point is Hawley's proposal that Congress ban mifepristone by revoking its federal approval. The Center describes Hawley and other lawmakers as attempting to ban the drug despite its decades-long safety record, which criticizes the proposal on safety grounds, so we labeled it Condemned.

    This label describes the statement's response within the context above.

  2. Jon HustedUnited States Senator for Ohio, responding to questions from Axios; his answer is reported in paraphrase, not quoted directly

    Before this statement

    Axios reported that Hawley's push was elevating an issue many Republicans hoped to avoid before the midterms, and that additional abortion restrictions could cost the party support in key races. It asked senators, including Husted and Thom Tillis, for their positions.

    "Sen. Jon Husted (R-Ohio), who faces a competitive reelection race, told Axios he hasn't seen Hawley's bill when asked for his position on it."
    Explicitly stayed out

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Asked by Axios for his position on Hawley's bill to ban mifepristone, Senator Jon Husted said he had not seen it. Axios reported his answer in paraphrase and did not publish a direct quotation, so no words of Husted's own are on the record; the excerpt held here is the reporter's sentence, quoted verbatim from the source. Husted was facing a competitive reelection race in Ohio at the time.

    After the statement

    Senator Thom Tillis gave Axios the same answer, adding "No" when asked whether Republicans were discussing the issue at all. Senate health committee chairman Bill Cassidy separately told MS NOW he had not seen the legislation.

    Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    Husted was asked directly for his position and withheld it, which is a refusal rather than a substantive response. The closest competing label is a finding that this is not a position event at all, since not having read a bill can be a plain statement of fact rather than an evasion. That loses because the question put to him was expressly for his position, and Axios reported the answer alongside Tillis's matching reply. This record carries a lower grade of evidence than the others in the case: the source paraphrases rather than quotes, so the substance is attributable to Husted but the wording is the reporter's.

    This label describes the statement's response within the context above.

  3. Thom TillisUnited States Senator for North Carolina, responding to questions from Axios

    Before this statement

    Axios reported that additional abortion restrictions could cost Republicans support in competitive races, and asked senators, including Tillis and Jon Husted, for their positions on the bill.

    "No."
    Explicitly stayed out

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Asked by Axios for his position on Hawley's bill, Senator Thom Tillis said he had not seen it. Asked whether Republicans were talking about the issue in general, he answered no.

    After the statement

    Senator Jon Husted, who faced a competitive reelection race, gave Axios the same answer about the bill; his response is recorded separately, though the report paraphrases rather than quotes him.

    Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    Tillis withholds a position on the bill and then closes down the broader subject, which is a refusal rather than a substantive response. The closest competing label is a finding that this is not a position event at all, since not having read a bill can be a simple statement of fact. That loses because the exchange was an express request for his position and he declined it twice, the second time foreclosing discussion of the issue itself.

    This label describes the statement's response within the context above.

  4. Josh HawleyUnited States Senator for Missouri, responding to questions from AxiosDirectly involved

    Before this statement

    Axios reported that Hawley's push was elevating an issue many Republicans hoped to avoid before the midterms.

    "This isn't about a political cycle, this is about protecting the health and safety of women, and also protecting the unborn."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Asked by Axios about Republican unease that his bill would raise abortion before the midterm elections, Hawley said the measure was not driven by the electoral calendar but by protecting women's health and the unborn. He added that opposition to abortion is "a foundational issue for the Republican Party" and that anti-abortion voters are the party's most dependable.

    After the statement

    The same report recorded that Senator John Cornyn had endorsed the bill while Senators Thom Tillis and Jon Husted each said they had not seen it.

    Hawley's abortion pill move puts Republican senators in a bind · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    He defends that proposition against the objection that it is electorally reckless, restating its justification rather than qualifying it. The closest competing label is “Mixed or conditional”, since he is responding to a political objection rather than making a fresh policy argument. That loses because he concedes nothing and attaches no condition; the remark reaffirms the ban on the same grounds he gave when introducing it.

    This label describes the statement's response within the context above.

  5. Josh HawleyU.S. senator from MissouriDirectly involved

    Before this statement

    Josh Hawley's proposal would require withdrawal of mifepristone's approval for pregnancy termination. A House companion was introduced by Diana Harshbarger.

    "Congress should ban mifepristone"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Josh Hawley argued that restoring earlier FDA restrictions would be insufficient because later administrations could undo them.

    After the statement

    Hawley argued that later administrations could reverse FDA restrictions, making a legislative ban necessary.

    Why this label?

    Josh Hawley argues for Hawley's mifepristone ban. Hawley argued that later administrations could reverse FDA restrictions, making a legislative ban necessary.

    This label describes the statement's response within the context above.

  6. Alexis McGill JohnsonPresident and chief executive of the Planned Parenthood Action Fund, in a statement reported by MS NOW

    Before this statement

    Mifepristone has been approved in the United States since 2000 and the FDA has said it has identified no new safety concerns with the drug.

    "This is yet another effort from abortion opponents to restrict access to care and spread even more misinformation about a safe and effective medication that millions of people have used."
    Condemned

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Planned Parenthood Action Fund president and chief executive Alexis McGill Johnson condemned Hawley's bill as an attempt to restrict access to abortion care and to spread misinformation about mifepristone, which she described as a safe and effective medication used by millions.

    After the statement

    Hawley's asserted complication rate was drawn from a non-peer-reviewed paper that more than 250 reproductive health researchers criticised.

    Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.

    Why this label?

    McGill Johnson rejects the proposition and its evidentiary basis together. The closest competing label is “Challenged the characterization”, since much of the sentence contests Hawley's factual account of the drug's safety. That loses because the passage also condemns the legislative effort itself as a restriction on care, which is a substantive rejection of the conduct under scrutiny and not merely a dispute about how the drug is described.

    This label describes the statement's response within the context above.

  7. Chuck SchumerSenate Minority Leader and United States Senator for New York, in a statement to MS NOW

    Before this statement

    The bill had been introduced two days earlier and would need Democratic votes to advance in the Senate, which Axios reported it would not get.

    "inconceivably cruel and radical"
    Condemned

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    In a statement to MS NOW, Senate Minority Leader Chuck Schumer described Hawley's bill to revoke the FDA's approval of mifepristone as inconceivably cruel and radical.

    After the statement

    MS NOW reported the same week that anti-abortion groups were pressing Republican leadership to take the bill up regardless of its prospects.

    Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.

    Why this label?

    Schumer's words are directed at that bill and reject it in the strongest terms. The closest competing label is minimizes, in the sense that dismissing a proposal as radical can work to place it outside serious debate rather than to argue against it. That loses because the characterisation is plainly condemnatory rather than a downplaying of anyone's concern, and it is addressed squarely at the legislation under scrutiny.

    This label describes the statement's response within the context above.

  8. Claire Cook-CallenExecutive director, Progress MO

    Before this statement

    Josh Hawley's proposal would require withdrawal of mifepristone's approval for pregnancy termination. A House companion was introduced by Diana Harshbarger.

    "ignoring the will of the voters"
    Condemned

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Claire Cook-Callen opposed Hawley's ban proposal, arguing that it conflicts with scientific evidence and Missouri's abortion-rights vote.

    After the statement

    Cook-Callen invoked Missouri voters' decision to restore abortion rights and disputed Hawley's scientific argument.

    ABC 17 reports responses to Hawley's proposed mifepristone banWales's direct statement to ABC 17, paragraph 28; Cook-Callen's direct statements to ABC 17, paragraphs 32-37

    Why this label?

    Claire Cook-Callen argues against Hawley's mifepristone ban. Cook-Callen invoked Missouri voters' decision to restore abortion rights and disputed Hawley's scientific argument.

    This label describes the statement's response within the context above.

  9. Janet MoranaExecutive director, Priests for Life

    Before this statement

    Josh Hawley's proposal would require withdrawal of mifepristone's approval for pregnancy termination. A House companion was introduced by Diana Harshbarger.

    "This bill puts the focus on the women harmed"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Janet Morana supported Hawley's bill as a response to harm she attributes to medication abortion.

    After the statement

    Morana argued that the proposed bill would address injuries she attributes to medication abortion.

    Janet Morana statement supporting Hawley's mifepristone billSeparately attributed Janet Morana statement

    Why this label?

    Janet Morana argues for Hawley's mifepristone ban. Morana argued that the proposed bill would address injuries she attributes to medication abortion.

    This label describes the statement's response within the context above.

  10. Emily WalesPresident and CEO, Planned Parenthood Great Plains

    Before this statement

    Josh Hawley's proposal would require withdrawal of mifepristone's approval for pregnancy termination. A House companion was introduced by Diana Harshbarger.

    "This bill ignores both"
    Condemned

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Emily Wales opposed the bill, arguing that it disregards medical evidence and Missouri voters' support for abortion access.

    After the statement

    Wales's reference to both concerned medical experts and voters.

    ABC 17 reports responses to Hawley's proposed mifepristone banWales's direct statement to ABC 17, paragraph 28; Cook-Callen's direct statements to ABC 17, paragraphs 32-37

    Why this label?

    Emily Wales argues against Hawley's mifepristone ban. Wales's reference to both concerned medical experts and voters.

    This label describes the statement's response within the context above.

  11. Blair DarneyVice President for Domestic Research at the Guttmacher Institute, quoted by St. Louis Public Radio

    Before this statement

    St. Louis Public Radio published the report the day after Hawley introduced his bill on March 11, 2026. It quotes Hawley as saying that earlier administrations removed almost all of the safety protocols around mifepristone, "such that today it is almost wholly unregulated." Darney is one of the advocates and health providers the report cites in response.

    "The Food and Drug Administration regulates all drugs and devices on the market in the U.S. Mifepristone went through this rigorous process before it was originally approved in 2000 ... so mifepristone has been a highly studied and highly regulated drug."
    Challenged the characterization

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    St. Louis Public Radio reported that Blair Darney, Vice President for Domestic Research at the Guttmacher Institute, called Hawley's claims that mifepristone is unregulated false. She said the Food and Drug Administration regulates all drugs and devices on the market in the U.S. and that mifepristone went through a rigorous process before it was approved in 2000.

    After the statement

    The report next cites the FDA's website, which it says states that further reviews have "not identified any new safety concerns" with mifepristone.

    Josh Hawley calls on Congress to ban abortion pill mifepristone · St. Louis Public RadioParagraphs on Blair Darney, after the passage on advocates and health providers

    Why this label?

    Relative to Hawley's proposal that Congress ban mifepristone, Darney is reported as calling his claims that the drug is unregulated false, and she says the FDA regulates all drugs and that mifepristone went through a rigorous process before its 2000 approval. In the words quoted she does not address the ban itself, so we labeled it Challenged the characterization rather than Condemned.

    This label describes the statement's response within the context above.

  12. Diana HarshbargerUnited States Representative for Tennessee's 1st District, in an official press release introducing the House companion billDirectly involved

    Before this statement

    Hawley unveiled the Safeguarding Women from Chemical Abortion Act at a press conference on March 11, 2026, and his release said Harshbarger would introduce companion legislation in the House. That release carried a slightly different version of these remarks.

    "As a pharmacist for decades prior to now serving in U.S. House of Representatives, I believe every drug approved in the United States must meet the highest standards of safety, transparency, and medical oversight Yet the FDA under previous administrations has steadily dismantled critical safeguards surrounding the abortion drug mifepristone — removing in-person dispensing requirements, allowing the drug to be shipped through the mail, and limiting adverse event reporting so the most serious complications are no longer tracked. Evidence now suggests that real world risks to women are greater than the federal government has acknowledged. That’s why I’m proud to join Senator Hawley to introduce the Safeguarding Women from Chemical Abortion Act that would restore accountability and help ensure that women’s health and safety — not politics — guide federal drug policy."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Representative Diana Harshbarger said she was proud to join Senator Josh Hawley in introducing the Safeguarding Women from Chemical Abortion Act. She said that, as a pharmacist for decades, she believes every approved drug must meet the highest standards of safety and oversight, and that the FDA under earlier administrations had dismantled safeguards around mifepristone.

    After the statement

    Her release listed the bill's three provisions: withdrawing the FDA's approval of mifepristone for abortion, making its distribution and labeling for pregnancy termination violations of the Federal Food, Drug, and Cosmetic Act, and creating a private right of action for women harmed by chemical abortion to sue manufacturers. It named eight organizations as supporters, including Susan B. Anthony Pro-Life America and the Family Research Council.

    Harshbarger, Hawley Introduce Bill to Ban Chemical Abortion Drug · Diana HarshbargerPress release dated March 12, 2026, second paragraph (remarks attributed to Harshbarger).
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Harshbarger introduced the House companion bill and said she was proud to join Hawley in doing so, arguing that the FDA had removed safeguards and that the bill would restore accountability. Introducing and endorsing the ban is a direct defense of the proposal, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  13. Bill CassidyUnited States Senator for Louisiana and chairman of the Senate Committee on Health, Education, Labor and Pensions, responding to questions from MS NOWDirectly involved

    Before this statement

    S. 4066 had been referred to Cassidy's committee the previous day. He had held a hearing in January on what he called the dangers of mifepristone and had joined an amicus brief on the drug's dispensing rules. He was facing a primary challenge.

    "I haven't seen this particular legislation."
    Explicitly stayed out

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Asked about Hawley's bill, Senator Bill Cassidy, chairman of the Senate Health, Education, Labor and Pensions Committee to which it had been referred, told MS NOW that he opposes the current scope of availability of abortion pills, then added that he had not seen this particular legislation. He has not said whether his committee will take the bill up.

    After the statement

    The bill has received no committee action in the six months since. A Cassidy spokesperson referred questions to the senator's past work on the issue.

    Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.

    Why this label?

    Asked directly for his position on the bill, Cassidy closed the question by saying he had not seen it, while stating a general view on abortion pill availability. That is a refusal to take a position on the specific proposal. The closest competing label is “Defended or excused”, because he volunteered that he opposes the drug's current availability. That loses because this case is the congressional ban, not availability in the abstract; his general remark does not commit him to the bill, and the operative part of the answer withholds a position on it.

    This label describes the statement's response within the context above.

  14. Jamila PerrittObstetrician-gynecologist and president and chief executive of Physicians for Reproductive Health, in an organisational press release

    Before this statement

    Hawley had said the previous day that "the science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse."

    "the science is clear: mifepristone is safe, mifepristone is effective, and mifepristone is still medically indicated"
    Condemned

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Dr. Jamila Perritt, an obstetrician-gynecologist and president of Physicians for Reproductive Health, responded to Hawley's bill by stating that the scientific evidence establishes mifepristone as safe, effective and still medically indicated, using the same "the science is clear" construction Hawley had used to argue the opposite.

    After the statement

    PolitiFact later reported that more than 100 peer-reviewed studies support the FDA's assessment that serious complications occur in under 0.5 percent of cases.

    Senate Introduces Attack on Mifepristone · Physicians for Reproductive HealthOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.

    Why this label?

    Perritt rejects the clinical premise the ban rests on, in a statement her organisation issued expressly as a response to the bill. The closest competing label is “Challenged the characterization”, because on its face the sentence disputes a factual claim about the drug rather than addressing the legislation. That loses because the premise she rejects is the bill's sole stated justification, and the statement was issued as an objection to the bill; treating it as a narrow factual quarrel would understate a physicians' organisation's rejection of the proposal.

    This label describes the statement's response within the context above.

  15. Mini TimmarajuPresident and chief executive of Reproductive Freedom for All, in an organisational press release

    Before this statement

    Missouri voters approved a ballot measure protecting abortion access in 2024, which Timmaraju's statement invokes against the state's senior senator.

    "Let's not forget: Senator Hawley's own constituents voted to protect abortion access. But he and his extremist colleagues will not stop until they've banned abortion nationwide."
    Condemned

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Reproductive Freedom for All president and chief executive Mini Timmaraju condemned Hawley's bill, arguing that Missouri voters had themselves acted to protect abortion access and that the bill was a step toward a nationwide abortion ban.

    After the statement

    Missouri abortion opponents were reorganising for a further statewide vote in 2026 at the time of the statement.

    Reproductive Freedom for All Condemns Senator Hawley's Bill To Revoke FDA Approval of Mifepristone · Reproductive Freedom for AllOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Mini Timmaraju.

    Why this label?

    Timmaraju rejects the proposition and characterises it as part of a broader national ban effort. The closest competing label is “Challenged the characterization”, because she disputes Hawley's implicit claim to represent his constituents rather than arguing the pharmacology. That loses because the statement does not stop at contesting a description: it expressly rejects the legislative course itself as something that must be stopped.

    This label describes the statement's response within the context above.

  16. John CornynUnited States Senator for Texas, posting on his own account on XDirectly involved

    Before this statement

    Cornyn was in a difficult Republican primary in Texas when the bill was introduced. He was the first of seven Republicans to cosponsor it.

    "All in"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Senator John Cornyn posted "All in" on X the day after Hawley introduced the Safeguarding Women from Chemical Abortion Act, endorsing the bill. He formally joined as its first cosponsor the same day. Cornyn was facing a contested Republican primary in Texas at the time.

    After the statement

    Of the seven eventual Republican cosponsors, Cornyn is the only one to have made an attributed public statement about the bill.

    Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.

    Why this label?

    Cornyn's two words are brief but unambiguous in their context: they were posted in direct response to the bill's introduction and accompanied by his cosponsorship the same day. The closest competing label is unclear, given the brevity of the post. That loses because the target and direction are fixed by the surrounding facts, and the accompanying legislative act removes any doubt about which position the words express.

    This label describes the statement's response within the context above.

  17. Tony PerkinsPresident, Family Research Council

    Before this statement

    Josh Hawley's proposal would require withdrawal of mifepristone's approval for pregnancy termination. A House companion was introduced by Diana Harshbarger.

    "Congress must act"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Tony Perkins supported Hawley's bill, arguing that Congress should act if the FDA does not restrict mifepristone.

    After the statement

    Perkins urged congressional action if the FDA did not restrict the drug.

    Tony Perkins statement supporting the Hawley-Harshbarger bill · Family Research CouncilPerkins's original bill-specific statement

    Why this label?

    Tony Perkins argues for Hawley's mifepristone ban. Perkins urged congressional action if the FDA did not restrict the drug.

    This label describes the statement's response within the context above.

  18. Lila RoseFounder and president of Live Action, in a statement of support released through Senator Hawley's office

    Before this statement

    On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the FDA's approval of mifepristone for abortion. His release listed Live Action among the organizations supporting the bill and pointed readers to their statements.

    "The abortion pill has fueled a deadly and deeply inhumane abortion industry that has killed millions of preborn babies and leaves women abandoned to suffer the physical and emotional consequences alone. For years, the abortion lobby has marketed these drugs as safe and easy while concealing the truth: nearly every time a pregnant mother takes the abortion pill, it ends the life of her living human child, and far too many women are left without real medical care when they are hemorrhaging or have a blood infection due to the abortion pill. The next step is clear. The abortion pill must be banned. Senator Hawley’s legislation does exactly that. It is a necessary and urgent step to shut down this deadly abortion industry, including its dangerous mail order abortion business, and protect mothers and their children"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Lila Rose, founder and president of Live Action, said in a statement of support released through Senator Hawley's office that the abortion pill must be banned and that his legislation does exactly that. She called it a necessary and urgent step to shut down what she called a deadly abortion industry.

    After the statement

    The same two-page document also carries statements from the Family Research Council, Susan B. Anthony Pro-Life America and the Ethics and Public Policy Center, among others.

    Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Rose said the abortion pill must be banned and that Hawley's legislation does exactly that, calling it a necessary and urgent step. That is direct support for the ban, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  19. AAPLOG ActionAdvocacy arm of the American Association of Pro-Life Obstetricians and Gynecologists, in a statement of support released through Senator Hawley's office

    Before this statement

    On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the FDA's approval of mifepristone for abortion. His release listed the American Association of Pro-Life OBGYNs Action among the organizations supporting the bill and pointed readers to their statements.

    "AAPLOG Action, the advocacy arm of the American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG), supports the Safeguarding Women from Chemical Abortion Act, and thanks Senator Hawley for introducing this important legislation. The Safeguarding Women from Chemical Abortion Act would withdraw approval of mifepristone for use in induced abortion. When the FDA illegally fast-tracked its original approval they recognized that this drug had significant risks – even then. In recent years, important safeguards – including in-person dispensing of mifepristone and follow-up care – have been removed, making mifepristone available through the mail and without medical oversight. This has significantly increased the risks not only our preborn patient, but also our maternal patient. Women deserve better. We are committed to providing excellent, evidence-based healthcare to both our patients, and removing mifepristone’s approval for induced abortion is a great step towards that goal. AAPLOG Action urges Congress to pass the Safeguarding Women from Chemical Abortion Act."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    AAPLOG Action, the advocacy arm of the American Association of Pro-Life Obstetricians and Gynecologists, said in a statement of support released through Senator Hawley's office that it supports the bill and urges Congress to pass it. The statement calls removing mifepristone's approval for induced abortion a great step toward the evidence-based healthcare it says it is committed to providing.

    After the statement

    The same two-page document carries statements from seven other groups, among them Susan B. Anthony Pro-Life America, Students for Life of America and Alliance Defending Freedom.

    Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. AAPLOG Action said it supports the bill, thanked Hawley, and urged Congress to pass it. That is direct support for the ban, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  20. Penny NanceCEO and president of Concerned Women for America and president of its Legislative Action Committee, in a statement of support released through Senator Hawley's office

    Before this statement

    On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the FDA's approval of mifepristone for abortion. His release listed Concerned Women for America among the organizations supporting the bill and pointed readers to their statements.

    "Claims that chemical abortion drugs are just as safe as Tylenol are simply not true. The FDA's own black box label on Mifepristone warns that one in 25 women will end up in the emergency room. This extremely dangerous drug has often been administered without medical oversight and has been used to coerce women into believing that abortion is as safe and easy as just popping a pill. Instead, women are left struggling to recover from the physical effects of Mifepristone on top of the psychological trauma of ending the life of their baby. Concerned Women for America is grateful for Sen. Hawley's efforts to end the use of Mifepristone for both destroying the lives of innocent babies and irreversibly harming their mothers"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Penny Nance, CEO and president of Concerned Women for America, said in a statement of support released through Senator Hawley's office that claims chemical abortion drugs are as safe as Tylenol are not true. She said Concerned Women for America is grateful for Hawley's efforts to end the use of the drug.

    After the statement

    The same two-page document carries statements from seven other groups, among them Live Action, the Family Research Council and AAPLOG Action.

    Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Nance said Concerned Women for America is grateful for Hawley's efforts to end the use of mifepristone and called the drug extremely dangerous. That is direct support for ending the drug's use through the bill, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  21. Kristen WaggonerPresident of Alliance Defending Freedom, in a statement of support released through Senator Hawley's office

    Before this statement

    On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the FDA's approval of mifepristone for abortion. His release listed Alliance Defending Freedom among the organizations supporting the bill and pointed readers to their statements.

    "For too long, the FDA's reckless disregard for women's health has sent tens of thousands to the emergency room after taking chemical abortion drugs. The agency now allows these drugs to be distributed online without even one in-person doctor visit, creating a dangerous tool for abusers and human traffickers to coerce and harm women – including our client Rosalie Markezich. Women deserve better than an unlawful regulatory regime that jeopardizes their health and safety and ends the lives of their children. We are grateful to Senator Hawley for introducing legislation that puts women and their children first by removing this high-risk drug from the market"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Kristen Waggoner, president of Alliance Defending Freedom, said in a statement of support released through Senator Hawley's office that she was grateful to him for introducing legislation removing what she called a high-risk drug from the market. She called the current regulatory regime unlawful and said it jeopardizes women's health and safety.

    After the statement

    The same two-page document carries statements from seven other groups, among them Concerned Women for America, Students for Life of America and the Ethics and Public Policy Center.

    Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Waggoner thanked Hawley for legislation removing what she called a high-risk drug from the market and called the current regulatory regime unlawful. That is direct support for the ban, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  22. Kristan HawkinsPresident of Students for Life of America and Students for Life Action, in a statement of support released through Senator Hawley's office

    Before this statement

    On March 11, 2026, Senator Josh Hawley introduced the Safeguarding Women from Chemical Abortion Act, which would withdraw the FDA's approval of mifepristone for abortion. His release listed Students for Life of America among the organizations supporting the bill and pointed readers to their statements.

    "Chemical Abortion is the number one method of abortion in the U.S., and it continues to be a cascading death sentence for preborn children and their mothers, and now even extending to the environment and endangered species. Students for Life has been at work for many years to address the no test, online distribution of Chemical Abortion Pills, which expose women to injury, infertility, and death, empowers abusers who force these pills on their victims, sometimes without their knowledge or consent. The Pro-Life Generation proudly supports Sen. Hawley’s ‘Safeguarding Women from Chemical Abortion Act’ that would revoke the Food and Drug Administration’s (FDA’s) original approval of Mifepristone. If passed, this law would save thousands of babies and women from these dangerous pills that should never have been put on the market. Health and safety standards and testing for things like environmental harms have been ignored or fast-tracked, by calling pregnancy a disease ‘cured’ by abortion. Students for Life Action is proud of Sen. Hawley’s leadership on this critical issue"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Kristan Hawkins, president of Students for Life of America and Students for Life Action, said in a statement of support released through Senator Hawley's office that the Pro-Life Generation supports his bill to revoke the FDA's original approval of mifepristone. She said the law would save thousands of babies and women from pills that should never have been put on the market.

    After the statement

    The same two-page document carries statements from seven other groups, among them the Family Research Council, Live Action and Alliance Defending Freedom.

    Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Hawkins said the Pro-Life Generation supports the bill and that the law would save thousands of babies and women from pills that should never have been put on the market. That is direct support for the ban, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  23. Ryan T. AndersonPresident of the Ethics and Public Policy Center, in a statement of support released through Senator Hawley's office

    Before this statement

    Hawley introduced the Safeguarding Women from Chemical Abortion Act on March 11, 2026. His release named the Ethics and Public Policy Center among the eight organizations supporting it and linked their statements of support.

    "Chemical abortion kills babies and harms women. Deadly to babies, it is significantly more dangerous to women than the FDA has let on. It is not a legitimate form of healthcare because it is not healthcare at all. A decent society would not approve it as if it were a legitimate medicine. Thank you to Senator Hawley for this bill revoking its misguided approval"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Ryan T. Anderson, president of the Ethics and Public Policy Center, said in a statement of support released through Senator Hawley's office that chemical abortion kills babies, harms women and is not a legitimate form of healthcare. He thanked Hawley for a bill revoking what he called the drug's misguided approval.

    After the statement

    The same two-page document carries statements of support from seven other organizations, including Susan B. Anthony Pro-Life America and Students for Life of America.

    Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The case's reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its FDA approval. Anderson thanks Hawley for the bill and calls the drug's approval misguided, which is clear support for the proposal, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  24. Marjorie DannenfelserPresident of Susan B. Anthony Pro-Life America (SBA Pro-Life America), in a statement of support released through Senator Hawley's office

    Before this statement

    Hawley introduced the bill on March 11, 2026. His release named Susan B. Anthony Pro-Life America among eight supporting organizations and provided a link to their statements of support.

    "At least 1.1 million children will be aborted this year in America – more than before Roe v. Wade was reversed – if the FDA won't act to stop it. The number 1 factor making abortion America’s top cause of death is mail-order abortion drugs, a dangerous relic of the Covid and Biden era that inexplicably continues to this day. This makes it impossible for states to protect women and children, creating a severe public health crisis. The Safeguarding Women from Chemical Abortion Act would address this head-on by withdrawing the politicized FDA approval of these dangerous abortion drugs. We are thankful to Senator Hawley and Congresswoman Harshbarger for understanding the gravity of this situation and for their work to find ways that Congress can step up to address it"
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Marjorie Dannenfelser, president of SBA Pro-Life America, said the Safeguarding Women from Chemical Abortion Act would address what she called a severe public health crisis by withdrawing the FDA's approval of abortion drugs. She thanked Hawley and Harshbarger for understanding the gravity of the situation and for their work to find ways Congress can act.

    After the statement

    The same two-page document carries statements of support from seven other organizations, including the Family Research Council, Live Action and Students for Life of America.

    Statements of Support for the Safeguarding Women from Chemical Abortion Act · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

    Why this label?

    The reference point is Hawley's proposal that Congress ban mifepristone by withdrawing its federal approval. Dannenfelser said the bill would address what she called a severe public health crisis by withdrawing the FDA's approval of abortion drugs, and thanked Hawley and Harshbarger for their work to find ways Congress can act. That is direct support for the ban, so we labeled it Defended or excused.

    This label describes the statement's response within the context above.

  25. Josh HawleyUnited States Senator for Missouri, in an official press release announcing his own legislationDirectly involved

    Before this statement

    Hawley had spent the previous year pressing the Food and Drug Administration to review mifepristone's safety and had grown frustrated with the pace of that review. He announced the bill at a Capitol Hill press conference alongside anti-abortion movement leaders.

    "The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse."
    Defended or excused

    Case context: Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?

    Full statement and sources

    Announcing the Safeguarding Women from Chemical Abortion Act, Senator Josh Hawley said the scientific evidence establishes that mifepristone is inherently dangerous to women and open to abuse. His bill would withdraw the drug's federal approval for pregnancy termination, make its distribution and labeling for that purpose violations of the Federal Food, Drug and Cosmetic Act, and allow women who say chemical abortion harmed them to sue its manufacturers.

    After the statement

    The safety claim rests on a 2025 Ethics and Public Policy Center paper that was not peer reviewed and was criticised by more than 250 reproductive health researchers. The bill was referred to the Senate Health, Education, Labor and Pensions Committee, where it has not moved.

    Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
    S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.

    Why this label?

    As the bill's author he advances that proposition directly, grounding it in an asserted safety finding. The closest competing label is “Challenged the characterization”, because the statement is framed as a factual correction to the FDA's assessment of the drug. That loses because the sentence is not confined to disputing a description: it is the stated justification for legislation he simultaneously introduced to enact the ban, which is a substantive endorsement of the conduct under scrutiny rather than a quarrel about labels.

    This label describes the statement's response within the context above.

Sources

(24)

Original text

S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress

S. 4066 — Safeguarding Women from Chemical Abortion Act, 119th Congress (opens in a new tab) · United States CongressS. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.
Read source (opens in a new tab)

Relevant passage: S. 4066, 119th Congress, 2nd Session. Sponsor: Sen. Josh Hawley. Introduced March 11, 2026; referred to the Senate Committee on Health, Education, Labor and Pensions.

About this source

The bill at issue in this case. It would withdraw the Food and Drug Administration's approval of mifepristone for pregnancy termination, make distributing and labeling the drug for that purpose violations of the Federal Food, Drug and Cosmetic Act, and create a private right of action for women who say chemical abortion harmed them to sue manufacturers. Legislative status and the cosponsor roster were verified against the GovTrack published record (bill 428713) on September 18, 2026, because congress.gov blocked access: seven Republican cosponsors, none withdrawn, the most recent joining June 23, 2026, and no action beyond committee referral. The identical House companion is H.R. 7902, introduced by Rep. Diana Harshbarger on March 12, 2026.

Published
Accessed
Archived copy (opens in a new tab)

Emailed statement

Emailed reply from GenBioPro to Dispute Index declining to comment on Hawley's mifepristone bill

Emailed reply from GenBioPro to Dispute Index declining to comment on Hawley's mifepristone bill
Hi Ben, Reaching out for GenBioPro. At this time, the company prefers not to comment. Thanks, Emma
· GenBioProEmailed reply on behalf of GenBioPro from Feldman Strategies, September 25, 2026 (UTC).

Full email

Hi Ben, Reaching out for GenBioPro. At this time, the company prefers not to comment. Thanks, Emma

Relevant passage: Emailed reply on behalf of GenBioPro from Feldman Strategies, September 25, 2026 (UTC).

Excerpt

"At this time, the company prefers not to comment."

About this source

Emailed reply sent on behalf of GenBioPro by Emma Thomas of its public relations firm, Feldman Strategies, to a Dispute Index request for the company's response to Sen. Josh Hawley's bill to ban mifepristone. The company declined to comment.

Author
Emma Thomas, Feldman Strategies, for GenBioPro
Published
Accessed
Archived copy (opens in a new tab)

Reporting

ABC 17 reports responses to Hawley's proposed mifepristone ban

ABC 17 reports responses to Hawley's proposed mifepristone ban (opens in a new tab)Wales's direct statement to ABC 17, paragraph 28; Cook-Callen's direct statements to ABC 17, paragraphs 32-37
Read source (opens in a new tab)

Relevant passage: Wales's direct statement to ABC 17, paragraph 28; Cook-Callen's direct statements to ABC 17, paragraphs 32-37

About this source

Contains statements by Emily Wales, Claire Cook-Callen about abc 17 reports responses to hawley's proposed mifepristone ban.

Published
Accessed
Archived copy (opens in a new tab)

Analysis

Josh Hawley explains why Congress should ban mifepristone

Read source (opens in a new tab)

Relevant passage: Final policy argument

About this source

Contains statements by Josh Hawley about josh hawley explains why congress should ban mifepristone.

Author
Josh Hawley
Published
Accessed

Original text

H.R. 7902 as introduced in the House

H.R. 7902 as introduced in the House (opens in a new tab)Official introduced bill, header and sections 2-3
Read source (opens in a new tab)

Relevant passage: Official introduced bill, header and sections 2-3

About this source

Diana Harshbarger introduced H.R. 7902, the House companion proposing to withdraw mifepristone's approval for pregnancy termination and create a federal damages claim.

Published
Accessed
Archived copy (opens in a new tab)

Official statement

Janet Morana statement supporting Hawley's mifepristone bill

Read source (opens in a new tab)

Relevant passage: Separately attributed Janet Morana statement

About this source

Contains statements by Janet Morana about hawley's mifepristone bill.

Published
Accessed

Official statement

Tony Perkins statement supporting the Hawley-Harshbarger bill

Tony Perkins statement supporting the Hawley-Harshbarger bill (opens in a new tab) · Family Research CouncilPerkins's original bill-specific statement
Read source (opens in a new tab)

Relevant passage: Perkins's original bill-specific statement

About this source

Contains statements by Tony Perkins about the hawley-harshbarger bill.

Published
Accessed
Archived copy (opens in a new tab)

Original text

U.S. Repro Watch: Six Updates You Won’t Want to Miss, 3.24.26

Read source (opens in a new tab)

Relevant passage: Item 1, "Lawmakers threaten mifepristone"

Excerpt

"Republican Senator Josh Hawley and other lawmakers are urging the FDA to rescind its approval of the abortion pill mifepristone, despite its decades-long safety record."

About this source

News update published on the Center for Reproductive Rights website.

Published
Accessed
Archived copy (opens in a new tab)

Reporting

Josh Hawley calls on Congress to ban abortion pill mifepristone

Josh Hawley calls on Congress to ban abortion pill mifepristone (opens in a new tab) · St. Louis Public RadioParagraphs on Blair Darney, after the passage on advocates and health providers
Read source (opens in a new tab)

Relevant passage: Paragraphs on Blair Darney, after the passage on advocates and health providers

Excerpt

"The Food and Drug Administration regulates all drugs and devices on the market in the U.S."

About this source

St. Louis Public Radio report, published March 12, 2026, on Senator Josh Hawley's announcement of a bill to withdraw FDA approval of mifepristone, including responses from advocates and health providers.

Author
Sarah Fentem
Published
Accessed
Archived copy (opens in a new tab)

Official statement

Letter to Congress on the Safeguarding Women from Chemical Abortion Act (April 1, 2026)

Letter to Congress on the Safeguarding Women from Chemical Abortion Act (April 1, 2026) (opens in a new tab)Fifth paragraph and first sentence of the sixth paragraph of the letter, before the closing
Read source (opens in a new tab)

Relevant passage: Fifth paragraph and first sentence of the sixth paragraph of the letter, before the closing

Excerpt

"We are very grateful for your leadership in addressing this serious moral issue, and we urge your colleagues in both the House and Senate to support and pass this bill."

About this source

Official letter from the USCCB Committee on Pro-Life Activities to Senator Josh Hawley and Representative Diana Harshbarger, dated April 1, 2026, stating support for S. 4066 and H.R. 7902.

Author
Most Reverend Daniel E. Thomas
Published
Accessed

Official statement

Statements of Support for the Safeguarding Women from Chemical Abortion Act

Statements of Support for the Safeguarding Women from Chemical Abortion Act (opens in a new tab) · Josh HawleyPage 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.
Read source (opens in a new tab)

Relevant passage: Page 1, statement attributed to Marjorie Dannenfelser, President of SBA Pro-Life America.

Excerpt

"We are thankful to Senator Hawley and Congresswoman Harshbarger for understanding the gravity of this situation"

About this source

Two-page compilation of statements of support for the bill from eight anti-abortion organizations, released by Senator Hawley's office and linked from his March 11, 2026 announcement of the bill.

Published
Accessed
Archived copy (opens in a new tab)

Reporting

Amid efforts to restrict mifepristone access, here’s what studies say about the medication

Read source (opens in a new tab)

Relevant passage: Third paragraph, on the one-in-ten complication figure.

Excerpt

"it wasn’t published in a peer-reviewed medical journal, and over 250 reproductive health researchers criticized it for methodological issues and its failure to disclose its data source"

About this source

PolitiFact's May 26, 2026 review of the research on mifepristone's safety, written as Republican senators cited a one-in-ten serious-complication figure. It reports where that figure comes from and summarizes the studies on complication rates.

Author
Madison Czopek
Published
Accessed
Archived copy (opens in a new tab)

Official statement

Tuberville Takes Action to Ban Dangerous Abortion Drug

Tuberville Takes Action to Ban Dangerous Abortion Drug (opens in a new tab) · Tommy TubervillePress release dated March 26, 2026, second paragraph (remarks attributed to Tuberville).
Read source (opens in a new tab)

Relevant passage: Press release dated March 26, 2026, second paragraph (remarks attributed to Tuberville).

Excerpt

"One in ten women who take this drug suffer serious health problems and it needs to be banned."

About this source

Tuberville's own press release announcing that he joined Hawley's bill. It quotes him, lists the bill's three provisions and cites one recent study on complication rates.

Published
Accessed
Archived copy (opens in a new tab)

Official statement

Harshbarger, Hawley Introduce Bill to Ban Chemical Abortion Drug

Harshbarger, Hawley Introduce Bill to Ban Chemical Abortion Drug (opens in a new tab) · Diana HarshbargerPress release dated March 12, 2026, second paragraph (remarks attributed to Harshbarger).
Read source (opens in a new tab)

Relevant passage: Press release dated March 12, 2026, second paragraph (remarks attributed to Harshbarger).

Excerpt

"I believe every drug approved in the United States must meet the highest standards of safety, transparency, and medical oversight"

About this source

Harshbarger's own press release announcing the House companion to Hawley's bill. It quotes both lawmakers, lists the bill's three provisions and names eight supporting organizations.

Published
Accessed
Archived copy (opens in a new tab)

Reporting

Trump's FDA pick Heidi Overton calls vaccines, mifepristone safe and effective in confirmation hearing

Read source (opens in a new tab)

Relevant passage: Paragraphs beginning "Senator Josh Hawley" and "In court, Hawley said."

Excerpt

"Senator Josh Hawley later challenged Overton's response, claiming, "that's not the FDA's position in court.""

About this source

Fierce Biotech reported on the September 24 Senate HELP Committee hearing for FDA commissioner nominee Heidi Overton. The report says Hawley challenged Overton over mifepristone regulation and the FDA's position in ongoing litigation.

Author
Darren Incorvaia and Marissa Russo
Published
Accessed

Reporting

Overton skirts senators' questions on abortion pill

Overton skirts senators' questions on abortion pill (opens in a new tab) · PoliticoParagraph beginning "Missouri Republican Josh Hawley" and the article's report of the Senate HELP Committee hearing.
Read source (opens in a new tab)

Relevant passage: Paragraph beginning "Missouri Republican Josh Hawley" and the article's report of the Senate HELP Committee hearing.

Excerpt

"Missouri Republican Josh Hawley, who staunchly opposes abortion, argued during the hearing that Overton's position on mifepristone clashes with the position the Trump administration has asserted in court battles over federal regulation of the medication."

About this source

Politico reported on the September 24 Senate HELP Committee hearing for FDA commissioner nominee Heidi Overton. Its report describes Hawley challenging Overton about mifepristone regulation and the administration's position in court.

Author
Lauren Gardner, Alice Miranda Ollstein and Robert King
Published
Accessed

Interview

EXCLUSIVE: Sen. Hawley says FDA commissioner nominee denied dangers of chemical abortion; demands answers amid lawsuits, official review

Read source (opens in a new tab)

Relevant passage: Paragraphs beginning "What I want to be real sure about" and "We've got to make sure."

Excerpt

"We've got to make sure that she is committed to ending the abortion drugs' availability in the state of Missouri and every other state. That they're going to put back in place the safety restrictions and they're going to follow the law."

About this source

Heartlander News identifies the remarks as a post-hearing interview with Hawley after Heidi Overton's September 24 Senate HELP Committee confirmation hearing. The article quotes Hawley calling for the FDA under Overton to end abortion-drug availability in Missouri and every other state and to restore safety restrictions.

Author
Michaela Estruth
Published
Accessed
Archived copy (opens in a new tab)

Official statement

Senate Introduces Attack on Mifepristone

Senate Introduces Attack on Mifepristone (opens in a new tab) · Physicians for Reproductive HealthOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.
Read source (opens in a new tab)

Relevant passage: Organizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Dr. Jamila Perritt.

Excerpt

"the science is clear: mifepristone is safe, mifepristone is effective, and mifepristone is still medically indicated"

About this source

The response from a national physicians' organization, answering Hawley's safety claim on clinical grounds. Perritt's phrasing deliberately mirrors Hawley's own "the science is clear" formulation from the bill announcement.

Published
Accessed

Official statement

Reproductive Freedom for All Condemns Senator Hawley's Bill To Revoke FDA Approval of Mifepristone

Reproductive Freedom for All Condemns Senator Hawley's Bill To Revoke FDA Approval of Mifepristone (opens in a new tab) · Reproductive Freedom for AllOrganizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Mini Timmaraju.
Read source (opens in a new tab)

Relevant passage: Organizational press release, March 12, 2026, carrying a statement attributed to president and chief executive Mini Timmaraju.

Excerpt

"Let's not forget: Senator Hawley's own constituents voted to protect abortion access. But he and his extremist colleagues will not stop until they've banned abortion nationwide."

About this source

The organization's official response to the bill, notable for grounding its objection in the 2024 Missouri ballot measure protecting abortion access in Hawley's own state.

Published
Accessed
Archived copy (opens in a new tab)

Reporting

Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms

Anti-abortion groups to GOP: Act on mifepristone or pay in the midterms (opens in a new tab) · MS NOWMS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.
Read source (opens in a new tab)

Relevant passage: MS NOW, March 13, 2026. Report on the Republican and anti-abortion movement response to the Hawley bill.

Excerpt

"When asked, Sen. Bill Cassidy, R-La., chairman of the Health, Education, Labor and Pensions Committee, told MS NOW on Thursday he opposes the current scope of availability of abortion pills — before adding, "I haven't seen this particular legislation.""

About this source

Source for Bill Cassidy's response as chairman of the committee holding the bill, John Cornyn's "All in" post on X, Chuck Schumer's reaction, and Alexis McGill Johnson's statement. Also records that spokespeople for Susan Collins and Lisa Murkowski did not respond to questions about the bill, and that the two were the only Republican senators who declined to sign a letter to the Department of Health and Human Services calling for a mifepristone crackdown.

Published
Accessed
Archived copy (opens in a new tab)

Reporting

Hawley's abortion pill move puts Republican senators in a bind

Hawley's abortion pill move puts Republican senators in a bind (opens in a new tab) · AxiosAxios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.
Read source (opens in a new tab)

Relevant passage: Axios, March 19, 2026. Report on Senate Republican reaction to the Safeguarding Women from Chemical Abortion Act.

Excerpt

"Sen. Jon Husted (R-Ohio), who faces a competitive reelection race, told Axios he hasn't seen Hawley's bill when asked for his position on it. Sen. Thom Tillis (R-N.C.) likewise said he had not seen the bill."

About this source

The fullest available account of Senate Republican reluctance on the bill, with direct responses from Husted and Tillis, Hawley's reply to Axios, and Marjorie Dannenfelser's criticism of the Trump administration's handling of mifepristone litigation.

Author
Peter Sullivan
Published
Accessed
Archived copy (opens in a new tab)

Reporting

Hawley to push GOP officeholders, candidates to sign 'Declaration for Life'

Hawley to push GOP officeholders, candidates to sign 'Declaration for Life' (opens in a new tab) · The HillThe Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.
Read source (opens in a new tab)

Relevant passage: The Hill, September 16, 2026, 12:15 PM ET. Report on the Declaration for Life unveiling.

Excerpt

"Hawley's mifepristone bill has at least seven Republican co-sponsors but hasn't received much discussion within the Senate GOP conference since he introduced it."

About this source

Contemporaneous reporting on the September 16 event, naming Tony Perkins of the Family Research Council and the Christian musician Sean Feucht as joining Hawley at the unveiling, and recording Hawley's request that candidates in both parties sign the pledge. The same quotations appear in the syndicated version carried by Yahoo News.

Author
Alexander Bolton
Published
Accessed

Official statement

Hawley Unveils Declaration for Life with Christian Leaders

Hawley Unveils Declaration for Life with Christian Leaders (opens in a new tab) · Josh HawleyOfficial Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.
Read source (opens in a new tab)

Relevant passage: Official Senate office press release following the first Missouri Prayer Breakfast, held September 16, 2026, in the Kennedy Caucus Room of the Russell Senate Office Building. Includes the text of the four-page Declaration for Life.

Excerpt

"This Declaration for Life, written by pastors, is calling on everyday Christians across America to stand for life and confront the scourge of chemical abortion."

About this source

The primary record of the Declaration for Life, the pledge Hawley is asking officeholders and candidates to sign. The declaration states that the abortion drug is "nearly always fatal to the unborn child and frequently injurious to the mother," that mifepristone "can now be mailed into every state and city in America, regardless of local rules," and calls on Congress "to ban the chemical abortion drug mifepristone."

Author
Office of Senator Josh Hawley
Published
Accessed

Official statement

Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders

Hawley Introduces Bill to Ban Chemical Abortion Drug, Hosts Press Conference Featuring Pro-Life Testimonies & Leaders (opens in a new tab) · Josh HawleyOfficial Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.
Read source (opens in a new tab)

Relevant passage: Official Senate office press release announcing the introduction of the Safeguarding Women from Chemical Abortion Act.

Excerpt

"The science is clear: the chemical abortion drug is inherently dangerous to women and prone to abuse."

About this source

Hawley's own announcement of the bill, issued alongside a Capitol Hill press conference with anti-abortion movement leaders. It states the bill's three operative provisions and carries the quotation on which his safety claim rests.

Author
Office of Senator Josh Hawley
Published
Accessed
Archived copy (opens in a new tab)

Case updates

Tracking Josh Hawley's push to ban the abortion pill

Get an email if the mifepristone bill moves in committee or gains cosponsors, or if candidates sign or reject Hawley's Declaration for Life pledge.

Important updates only. Free. Confirm your email to start. Unsubscribe anytime. How we handle your email.

The newsletter

Follow disputes like this one.

New cases and significant updates to the record, in your inbox. Free.

You’ll confirm your subscription on Substack.

Share or embed this case

The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the case page.

Cite this record

Publisher
The Dispute Index
Title
Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?
First published
Last updated
Permalink
https://disputeindex.com/cases/congress-ban-abortion-pill-mifepristone-hawley

The Dispute Index. "Should Congress ban the abortion pill, mifepristone, as Josh Hawley has proposed?". First published: 2026-09-18. Last updated: 2026-09-26. https://disputeindex.com/cases/congress-ban-abortion-pill-mifepristone-hawley